Status:
COMPLETED
Cardiopulmonary Testing for Potential Pancreas Transplant Candidates
Lead Sponsor:
Oxford University Hospitals NHS Trust
Conditions:
Cardiovascular Risk Factor
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18-65 years
Brief Summary
Patients being assessed for Kidney Pancreas transplantation often have pre-existing co-morbid disease that contributes to structural cardiac and vascular disease. There is no consensus on optimal pre-...
Detailed Description
20 participants will be recruited to a blinded observational study. Patients referred for pancreas kidney transplantation assessment will be provided information about the study. They will subsequentl...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent
- Diagnosed with type 1 diabetes mellitus with estimated glomerular filtration rate (eGFR)\<20ml/min or on renal replacement therapy referred for simultaneous pancreas-kidney (SPK) transplant
Exclusion
- Participant unable to undergo CPET testing due to limitation on mobility or limb movement
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 14 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04312802
Start Date
March 1 2018
End Date
September 14 2024
Last Update
January 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Churchill Hospital
Oxford, Oxfordshire, United Kingdom